Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation
ConclusionsThe uptake of DOACs was rapid and spurred an increase in new users of oral anticoagulants for atrial fibrillation from 2010 to 2015 in Norway. The mean CHA2DS2-VASc score did not change substantially during this period. Vascular disease, heart failure, and diabetes were associated with initiation of warfarin, and previous stroke, age 65 –74 and female sex with initiation of DOACs.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Atrial Fibrillation | Cardiology | Congestive Heart Failure | Coumadin | Diabetes | Drugs & Pharmacology | Endocrinology | Heart | Heart Failure | Hypertension | Ischemic Stroke | Norway Health | Pradaxa | Stroke | Thrombosis | Warfarin